Effects of Dynorphin 1-13 on Heroin Addiction - 1

Completed · Phase 2

Conditions studied: Opioid-Related Disorders, Substance Withdrawal Syndrome

In brief

The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.

Key facts

Study ID

NCT00000244

Run by

University of Minnesota

People needed

0

Starts

1994-08-01

Expected to finish

1997-03-01

Last updated by the study team

2015-05-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• opiate addict between the ages of 18-55

You may not qualify if…

• Regular abuse of other drugs, unstable medical conditions

Where it is running

• U of Minnesota School of Medicine — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.